Fort Washington Investment Advisors Inc. OH Has $23.52 Million Position in Chemed Corporation $CHE

Posted by Brenda Bartman on Jun 29th, 2026

Fort Washington Investment Advisors Inc. OH boosted its holdings in Chemed Corporation (NYSE:CHE – Free Report) by 20.3% during the first quarter, Holdings Channel reports. The fund owned 62,264 shares of the company’s stock after purchasing an additional 10,498 shares during the period. Fort Washington Investment Advisors Inc. OH’s holdings in Chemed were worth $23,520,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also added to or reduced their stakes in the company. Pictet Asset Management Holding SA boosted its position in Chemed by 5.0% during the first quarter. Pictet Asset Management Holding SA now owns 2,305 shares of the company’s stock worth $871,000 after purchasing an additional 110 shares during the period. MBE Wealth Management LLC raised its position in shares of Chemed by 11.2% in the first quarter. MBE Wealth Management LLC now owns 687 shares of the company’s stock valued at $259,000 after purchasing an additional 69 shares during the period. Louisiana State Employees Retirement System acquired a new stake in shares of Chemed during the 1st quarter worth about $1,549,000. KFG Wealth Management LLC lifted its stake in shares of Chemed by 14.1% during the 1st quarter. KFG Wealth Management LLC now owns 791 shares of the company’s stock worth $299,000 after buying an additional 98 shares during the last quarter. Finally, Silver Oak Securities Incorporated lifted its stake in shares of Chemed by 21.3% during the 1st quarter. Silver Oak Securities Incorporated now owns 717 shares of the company’s stock worth $271,000 after buying an additional 126 shares during the last quarter. Institutional investors and hedge funds own 95.85% of the company’s stock.

Analyst Upgrades and Downgrades

A number of brokerages recently commented on CHE. Royal Bank Of Canada upped their price target on shares of Chemed from $422.00 to $436.00 and gave the company a “sector perform” rating in a research note on Monday, April 27th. Weiss Ratings upgraded shares of Chemed from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Wednesday, April 29th. Wall Street Zen cut Chemed from a “buy” rating to a “hold” rating in a report on Monday, June 8th. Finally, Zacks Research raised Chemed from a “strong sell” rating to a “hold” rating in a research report on Monday, April 27th. Two investment analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $501.50.

Get Our Latest Analysis on Chemed

Insider Transactions at Chemed

In other Chemed news, CEO Kevin J. Mcnamara sold 2,000 shares of the business’s stock in a transaction dated Friday, May 1st. The shares were sold at an average price of $421.13, for a total value of $842,260.00. Following the completion of the sale, the chief executive officer owned 90,219 shares of the company’s stock, valued at $37,993,927.47. The trade was a 2.17% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Andrea R. Lindell sold 1,347 shares of the stock in a transaction that occurred on Tuesday, June 9th. The stock was sold at an average price of $447.33, for a total transaction of $602,553.51. Following the transaction, the director owned 4,578 shares in the company, valued at approximately $2,047,876.74. The trade was a 22.73% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders own 3.33% of the company’s stock.

Chemed Stock Down 0.3%

CHE stock opened at $461.88 on Monday. The company has a debt-to-equity ratio of 0.11, a current ratio of 0.85 and a quick ratio of 0.83. The stock has a market capitalization of $6.13 billion, a price-to-earnings ratio of 25.17, a PEG ratio of 1.74 and a beta of 0.54. The business’s fifty day moving average price is $426.41 and its two-hundred day moving average price is $425.04. Chemed Corporation has a fifty-two week low of $365.20 and a fifty-two week high of $562.77.

Chemed (NYSE:CHE – Get Free Report) last posted its earnings results on Thursday, April 23rd. The company reported $5.65 earnings per share for the quarter, topping analysts’ consensus estimates of $5.30 by $0.35. The company had revenue of $657.51 million during the quarter, compared to the consensus estimate of $659.22 million. Chemed had a return on equity of 27.18% and a net margin of 10.23%.The company’s revenue was up 1.6% on a year-over-year basis. During the same quarter last year, the firm earned $5.63 earnings per share. Chemed has set its FY 2026 guidance at 24.000-24.75 EPS. On average, equities analysts anticipate that Chemed Corporation will post 22.3 earnings per share for the current year.

Chemed Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, June 16th. Shareholders of record on Thursday, May 28th were paid a $0.60 dividend. The ex-dividend date was Thursday, May 28th. This represents a $2.40 annualized dividend and a yield of 0.5%. Chemed’s payout ratio is 13.08%.

About Chemed

(Free Report)

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.